Article
Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis.
Graduate School of Medicine, R221, University of Tennessee, 1924 Alcoa Highway, Knoxville, TN 37920, USA.
Journal of Molecular Biology (impact factor:
4).
02/2004;
335(3):833-42.
pp.833-42
Source: PubMed
-
Citations (0)
- Cited In (17)
-
Dataset: Structural Biology Protein Aggregation Disease
-
Article: Fibril-forming motifs are essential and sufficient for the fibrillization of human Tau.
[show abstract] [hide abstract]
ABSTRACT: The misfolding of amyloidogenic proteins including human Tau protein, human prion protein, and human α-synuclein is involved in neurodegenerative diseases such as Alzheimer disease, prion disease, and Parkinson disease. Although a lot of research on such amyloidogenic proteins has been done, we do not know the determinants that drive these proteins to form fibrils and thereby induce neurodegenerative diseases. In this study, we want to know the role of fibril-forming motifs from such amyloidogenic proteins in the fibrillization of human Tau protein. As evidenced by thioflavin T binding and turbidity assays, transmission electron microscopy, and circular dichroism, fibril-forming motifs are essential and sufficient for the fibrillization of microtubule-associated protein Tau: only when both of its fibril-forming motifs, PHF6 and PHF6*, are deleted can recombinant human Tau fragment Tau(244-372) lose its ability to form fibrils, and the insertion of unrelated fibril-forming motifs from other amyloidogenic proteins, such as human prion protein, yeast prion protein, human α-synuclein, and human amyloid β, into the disabled Tau protein can retrieve its ability to form fibrils. Furthermore, this retrieval is independent of the insertion location on Tau(244-372). We demonstrate for the first time that insertion of fibril-forming motifs can replace PHF6/PHF6* motifs, driving human Tau protein to form fibrils with different morphologies and different kinetic parameters. Our results suggest that fibril-forming motifs play a key role in the fibrillization of human Tau protein and could be the determinants of amyloidogenic proteins tending to misfold, thereby causing the initiation and development of neurodegenerative diseases. Our study also touches on the importance of amyloid "strains": changes to the amyloidgenic driver region results in altered structural morphologies at the macromolecular level.PLoS ONE 01/2012; 7(6):e38903. · 4.09 Impact Factor -
Article: Side-chain hydrophobicity and the stability of Aβ(16-22) aggregates.
[show abstract] [hide abstract]
ABSTRACT: Recent mutagenesis studies using the hydrophobic segment of Aβ suggest that aromatic π-stacking interactions may not be critical for fibril formation. We have tested this conjecture by probing the effect of Leu, Ile and Ala mutation of the aromatic Phe residues at positions 19 and 20, on the double layer hexametric chains of Aβ fragment Aβ(16-22) using explicit solvent all-atom molecular dynamics. As these simulations rely on the accuracy of the utilized force fields, we have evaluated first the dynamic and stability dependence on various force fields of small amyloid aggregates. These initial investigations led us to choose AMBER99SB-ILDN as force field in multiple long molecular dynamics simulations of 100ns that probe the stability of the wild type and mutants oligomers. Single point and double point mutants confirm that size and hydrophobicity are key for the aggregation and stability of the hydrophobic core region (Aβ(16-22) ). This suggests as a venue for designing Aβ aggregation inhibitors the substitution of residues (especially Phe 19 and 20) in the hydrophobic region (Aβ(16-22) ) with natural and non-natural amino acids of similar size and hydrophobicity.Protein Science 09/2012; · 2.80 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
Abeta sequence
Alzheimer's disease amyloid peptide Abeta
amide protons
amyloid fibrils
amyloid protofilament structure
conformation
contiguous sequence elements 15-21
different residue positions
flexible elements extruded
hydrogen exchange
hydrogen-deuterium exchange
peptide likely
proline mutations destabilize fibrils
proline replacement
proline replacement fall
proline scanning data
proline substitution
single-proline replacement mutants
unstructured regions
wild-type fibrils